• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含6-氨基己酸的肽类:作为纤溶酶抑制剂的合成与评价

Peptides with 6-Aminohexanoic Acid: Synthesis and Evaluation as Plasmin Inhibitors.

作者信息

Purwin Maciej, Markowska Agnieszka, Bruzgo Irena, Rusak Tomasz, Surażyński Arkadiusz, Jaworowska Urszula, Midura-Nowaczek Krystyna

机构信息

Department of Organic Chemistry, Medical University of Bialystok, Mickiewicza 2A Str, 15-222 Białystok, Poland.

Department of Physical Chemistry, Medical University of Bialystok, Mickiewicza 2A Str, 15-222 Białystok, Poland.

出版信息

Int J Pept Res Ther. 2017;23(2):235-245. doi: 10.1007/s10989-016-9555-3. Epub 2016 Sep 19.

DOI:10.1007/s10989-016-9555-3
PMID:28491013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5401710/
Abstract

Fifteen new peptide derivatives of ɛ-aminocaproic acid (EACA) containing the known fragment -Ala-Phe-Lys- with an affinity for plasmin were synthesised in the present study. The synthesis was carried out a solid phase. The following compounds were synthesised: H-Phe-Lys-EACA-X, H-d-Ala-Phe-Lys-EACA-X, H-Ala-Phe-Lys-EACA-X, H-d-Ala-Phe-EACA-X and H-Ala-Phe-EACA-X, where X = OH, NH and NH-(CH)-NH. All peptides, except for those containing the sequence H-Ala-Phe-EACA-X, displayed higher inhibitory activity against plasmin than EACA. The most active and selective inhibitor of plasmin was the compound H-d-Ala-Phe-Lys-EACA-NH which inhibited the amidolytic activity of plasmin (IC = 0.02 mM), with the antifibrinolytic activity weaker than EACA. The resulting peptides did not affect the viability of fibroblast cells, colon cancer cell line DLD-1, breast MCF-7 and MDA-MB-231 cell lines.

摘要

在本研究中合成了15种含有已知片段-Ala-Phe-Lys-且对纤溶酶有亲和力的ε-氨基己酸(EACA)新肽衍生物。合成采用固相法进行。合成了以下化合物:H-Phe-Lys-EACA-X、H-d-Ala-Phe-Lys-EACA-X、H-Ala-Phe-Lys-EACA-X、H-d-Ala-Phe-EACA-X和H-Ala-Phe-EACA-X,其中X = OH、NH和NH-(CH)-NH。除了含有序列H-Ala-Phe-EACA-X的那些肽外,所有肽对纤溶酶的抑制活性均高于EACA。最具活性和选择性的纤溶酶抑制剂是化合物H-d-Ala-Phe-Lys-EACA-NH,它抑制纤溶酶的酰胺水解活性(IC = 0.02 mM),抗纤维蛋白溶解活性比EACA弱。所得肽不影响成纤维细胞、结肠癌细胞系DLD-1、乳腺癌MCF-7和MDA-MB-231细胞系的活力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b81/5401710/0e9f8bd6b20a/10989_2016_9555_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b81/5401710/0192453c0194/10989_2016_9555_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b81/5401710/b2fa5c541596/10989_2016_9555_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b81/5401710/0e9f8bd6b20a/10989_2016_9555_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b81/5401710/0192453c0194/10989_2016_9555_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b81/5401710/b2fa5c541596/10989_2016_9555_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b81/5401710/0e9f8bd6b20a/10989_2016_9555_Fig3_HTML.jpg

相似文献

1
Peptides with 6-Aminohexanoic Acid: Synthesis and Evaluation as Plasmin Inhibitors.含6-氨基己酸的肽类:作为纤溶酶抑制剂的合成与评价
Int J Pept Res Ther. 2017;23(2):235-245. doi: 10.1007/s10989-016-9555-3. Epub 2016 Sep 19.
2
Peptide inhibitors of plasmin.
Acta Pol Pharm. 1990;47(1-2):39-42.
3
Low molecular peptides as potential inhibitors of plasmin.
Acta Pol Pharm. 2007 Jul-Aug;64(4):355-8.
4
Short peptides containing L-lysine and epsilon-aminocaproic acid as potential plasmin inhibitors.
Pharmazie. 2009 Nov;64(11):765-7.
5
Cytotoxic activity of epsilon-aminocaproylamino acids in breast cancer MCF-7 and fibroblast cell lines.
Acta Pol Pharm. 2010 Mar-Apr;67(2):201-4.
6
Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.新型促生长抑素(sst)(4)选择性生长抑素(SRIF)激动剂。3. 适用于放射性标记的类似物。
J Med Chem. 2003 Dec 18;46(26):5597-605. doi: 10.1021/jm030245x.
7
Effect of short peptides containing lysine and epsilon-aminocaproic acid on fibrinolytic activity of plasmin and topoisomerase II action on supercoiled DNA.含赖氨酸和ε-氨基己酸的短肽对纤溶酶纤溶活性及拓扑异构酶II作用于超螺旋DNA的影响。
Acta Pol Pharm. 2013 May-Jun;70(3):431-4.
8
Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.具有N端Nin-For-Trp(Ftr)的强效肾素抑制肽的设计、构效关系及分子模拟研究:经P1-P1'苯丙氨酸-苯丙氨酸、斯塔汀、亮氨酸ψ[CH(OH)CH2]缬氨酸或亮氨酸ψ[CH2NH]缬氨酸取代修饰的血管紧张素原类似物
J Med Chem. 1988 Jan;31(1):18-30. doi: 10.1021/jm00396a006.
9
Synthesis and pharmacological activity of the N-terminal dermorphin tetrapeptide analogs with CH2-NH peptide bond isosteres.具有CH2-NH肽键电子等排体的N端德尔吗啡四肽类似物的合成及药理活性
Int J Pept Protein Res. 1992 Nov;40(5):437-44. doi: 10.1111/j.1399-3011.1992.tb00322.x.
10
Different assessment of plasmin with different substrates. In vitro alteration of plasmin, influence of epsilon-aminocaproic acid and tranexamic acid upon its activity.
Thromb Haemost. 1980 Jun 18;43(2):112-7.

引用本文的文献

1
The Importance of 6-Aminohexanoic Acid as a Hydrophobic, Flexible Structural Element.6-氨基己酸作为疏水性、柔性结构元件的重要性。
Int J Mol Sci. 2021 Nov 9;22(22):12122. doi: 10.3390/ijms222212122.
2
Strategies in Translating the Therapeutic Potentials of Host Defense Peptides.宿主防御肽治疗潜力的转化策略。
Front Immunol. 2020 May 22;11:983. doi: 10.3389/fimmu.2020.00983. eCollection 2020.

本文引用的文献

1
Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis.真性红细胞增多症患者血小板相关的纤溶抵抗。凝块回缩和等容红细胞单采术的影响。
Thromb Res. 2014 Jul;134(1):192-8. doi: 10.1016/j.thromres.2014.04.025. Epub 2014 May 2.
2
Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.用于治疗纤溶相关疾病的纤溶酶抑制剂的最新进展。
Med Res Rev. 2014 Nov;34(6):1168-216. doi: 10.1002/med.21315. Epub 2014 Mar 21.
3
Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries.
氨甲环酸在减少髋部和股骨手术患者术后失血及输血需求方面的作用。
Saudi J Anaesth. 2013 Jan;7(1):29-32. doi: 10.4103/1658-354X.109803.
4
Antifibrinolytic agents in current anaesthetic practice.目前麻醉实践中的抗纤维蛋白溶解剂。
Br J Anaesth. 2013 Oct;111(4):549-63. doi: 10.1093/bja/aet154. Epub 2013 May 9.
5
Tripeptides with non-code amino acids as potential serine proteases inhibitors.具有非编码氨基酸的三肽作为潜在的丝氨酸蛋白酶抑制剂。
J Enzyme Inhib Med Chem. 2013 Jun;28(3):639-43. doi: 10.3109/14756366.2011.651463. Epub 2012 Feb 3.
6
Efficacy and Safety of Tranexamic Acid in Control of Bleeding Following TKR: A Randomized Clinical Trial.氨甲环酸控制全膝关节置换术后出血的疗效与安全性:一项随机临床试验
Indian J Anaesth. 2009 Dec;53(6):667-71.
7
Short peptides containing L-lysine and epsilon-aminocaproic acid as potential plasmin inhibitors.
Pharmazie. 2009 Nov;64(11):765-7.
8
Characteristic response of astrocytes to plasminogen/plasmin to upregulate transforming growth factor beta 3 (TGFbeta3) production/secretion through proteinase-activated receptor-1 (PAR-1) and the downstream phosphatidylinositol 3-kinase (PI3K)-Akt/PKB signaling cascade.星形胶质细胞对纤溶酶原/纤溶酶的特征性反应,通过蛋白酶激活受体-1(PAR-1)和下游的磷脂酰肌醇 3-激酶(PI3K)-Akt/PKB 信号级联上调转化生长因子β3(TGFβ3)的产生/分泌。
Brain Res. 2009 Dec 11;1305:1-13. doi: 10.1016/j.brainres.2009.09.025. Epub 2009 Sep 16.
9
The role of plasminogen-plasmin system in cancer.纤溶酶原-纤溶酶系统在癌症中的作用。
Cancer Treat Res. 2009;148:43-66. doi: 10.1007/978-0-387-79962-9_4.
10
Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair.肝脏修复过程中肝细胞生长因子的激活需要纤溶酶介导的蛋白水解作用。
J Biol Chem. 2009 May 8;284(19):12917-23. doi: 10.1074/jbc.M807313200. Epub 2009 Mar 13.